This inventor holds 3 USPTO granted patents. Top assignees: Government of the United States, The United States of America, The United States of America as Represented by the Department of Health. Active years: 1979-1987.
Company Filing History:
1 out of 22 
1 out of 255 
1 out of 1,217 
Years Active: 1979-1987
Title: A Hameed Khan: Innovator in Antitumor Agents
Introduction
A Hameed Khan is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of antitumor agents, holding a total of 3 patents. His work focuses on innovative compounds that have the potential to treat various forms of cancer.
Latest Patents
One of his latest patents involves the use of aziridinyl quinones as antitumor agents. This patent discloses a compound known as 2,5-diaziridinyl-3,6-bis (carboethoxyamino)-1,4-benzoquinone, which has shown effectiveness in treating various forms of leukemia, B16 melanoma, Lewis lung carcinoma, and the ependymoblastoma brain tumor system. Another patent also highlights the use of aziridinyl quinones against transplanted tumors in mice, further emphasizing the compound's efficacy in several transplanted mouse tumor test systems.
Career Highlights
Throughout his career, A Hameed Khan has worked with the United States Government and various institutions. His research has contributed to advancements in cancer treatment, showcasing his dedication to improving healthcare outcomes.
Collaborations
A Hameed Khan has collaborated with notable individuals in his field, including John S Driscoll and Feng-te Chou. These collaborations have likely enriched his research and development efforts.
Conclusion
A Hameed Khan's innovative work in the development of antitumor agents demonstrates his commitment to advancing medical science. His contributions are significant in the ongoing fight against cancer, and his patents reflect a promising future for cancer treatment.